Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Central Nervous System Cancers
Histopathologic and molecular characterization of high-grade gliomas should now be standard practice, as specific markers used to define molecular subgroups among some anaplastic gliomas have been shown to have prognostic value. However, there are currently no targeted agents that have shown efficacy in the treatment of glioblastoma. The differential benefit from concurrent versus adjuvant temozolomide in patients with anaplastic gliomas continues to be unclear.
Category
  • CNS Cancers
  • Glioma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation